McNamara, Catherine
4 papers on CoChatORCID 0000-0002-2420-4820
Most cited papers
- Verified
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 3,163
- Verified
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 638
- Verified
Diabetes Text-Message Self-Management Support Program (SMS4BG): A Pilot Study
Dobson, R., Carter, K., Cutfield, R., Hulme, A., Hulme, R., McNamara, C., Maddison, R., Murphy, R., Shepherd, M., Strydom, J., et al. (2015) · JMIR mHealth and uHealth
Mobile Health and mHealth ApplicationsDiabetes Management and Education
Cited by 77
- Verified
Text message-based diabetes self-management support (SMS4BG): study protocol for a randomised controlled trial
Dobson, R., Whittaker, R., Jiang, Y., Shepherd, M., Maddison, R., Carter, K., Cutfield, R., McNamara, C., Khanolkar, M., & Murphy, R. (2016) · Trials
Mobile Health and mHealth ApplicationsDiabetes Management and Education
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free